Arabic Arabic English English French French German German
dark

BioSyent Releases Q2 and H1 2021 Financial Results

BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three and six months ended June 30, 2021. Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Engagement, Interoperability, and the Future of the Healthcare Tech Stack

Next Post

Cardior Raises €64M Series B to Advance Clinical Pipeline of RNA Therapeutics to Treat Cardiac Disease

Related Posts
Total
0
Share